Gene · 4882
Papers1,917
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,917
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The influence of physiological and pathological perturbations on blood-brain barrier function. | Front Neurosci | 2023 | 37937070 | PubTator, text mining | PubMed |
| Natriuretic Peptide Receptor B Protects Against Atrial Fibrillation by Controlling Atrial cAMP Via Phosphodiesterase 2. | Circ Arrhythm Electrophysiol | 2023 | 37933567 | PubTator, text mining | PubMed |
| E2/ER signaling mediates the meiotic arrest of goat intrafollicular oocytes induced by follicle-stimulating hormone. | J Anim Sci | 2023 | 37925610 | PubTator, text mining | PubMed |
| Advancements in Rift Valley fever vaccines: a historical overview and prospects for next generation candidates. | NPJ Vaccines | 2023 | 37925544 | PubTator, text mining | PubMed |
| Exercise performance is not improved in mice with skeletal muscle deletion of natriuretic peptide clearance receptor. | PLoS One | 2023 | 37917630 | PubTator, text mining | PubMed |
| Decreased HAT1 expression in granulosa cells disturbs oocyte meiosis during mouse ovarian aging. | Reprod Biol Endocrinol | 2023 | 37907924 | PubTator, text mining | PubMed |
| Exploring the Genetic Causes for Postnatal Growth Failure in Children Born Non-Small for Gestational Age. | J Clin Med | 2023 | 37892645 | PubTator, text mining | PubMed |
| TP53 mutations predict for poor outcomes in patients with newly diagnosed aggressive B-cell lymphomas in the current era. | Blood Adv | 2023 | 37851898 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing analysis reveals transcriptional heterogeneity of multiple primary lung cancer. | Clin Transl Med | 2023 | 37846760 | PubTator, text mining | PubMed |
| Once-weekly TransCon CNP (navepegritide) in children with achondroplasia (ACcomplisH): a phase 2, multicentre, randomised, double-blind, placebo-controlled, dose-escalation trial. | EClinicalMedicine | 2023 | 37823031 | PubTator, text mining | PubMed |
| The molecular regulatory mechanisms of meiotic arrest and resumption in Oocyte development and maturation. | Reprod Biol Endocrinol | 2023 | 37784186 | PubTator, text mining | PubMed |
| M6A methylation modification in autoimmune diseases, a promising treatment strategy based on epigenetics. | Arthritis Res Ther | 2023 | 37784134 | PubTator, text mining | PubMed |
| ESX1 gene as a potential candidate responsible for male infertility in nonobstructive azoospermia. | Sci Rep | 2023 | 37783880 | PubTator, text mining | PubMed |
| A Recurrent Mutation in Growth Hormone Receptor (GHR) Gene Underlying Laron-type Dwarfism in a Pakistani Family. | Yale J Biol Med | 2023 | 37780997 | PubTator, text mining | PubMed |
| Brain pericyte biology: from physiopathological mechanisms to potential therapeutic applications in ischemic stroke. | Front Cell Neurosci | 2023 | 37780206 | PubTator, text mining | PubMed |
| Relationship of atrial fibrillation and N terminal pro brain natriuretic peptide in heart failure patients. | ESC Heart Fail | 2023 | 37776150 | PubTator, text mining | PubMed |
| Identification and analysis of individuals who deviate from their genetically-predicted phenotype. | PLoS Genet | 2023 | 37733769 | PubTator, text mining | PubMed |
| Identification of a second genetic alteration in patients with SHOX deficiency individuals: a potential explanation for phenotype variability. | Eur J Endocrinol | 2023 | 37695807 | PubTator, text mining | PubMed |
| Use of whole exome sequencing for identification of genetic variants related to Growth Hormone Deficiency and Short Stature: A Family-Based Study. | Pak J Med Sci | 2023 | 37680843 | PubTator, text mining | PubMed |
| Pseudotemporal ordering of spatial lymphoid tissue microenvironment profiles trails Unclassified DLBCL at the periphery of the follicle. | Front Immunol | 2023 | 37680642 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4882/papers?page=6